1. Imugene (IMU) - PH's first child. B-Cell technology platform has been de-risked. Very undervalued at current MC. Drug supply deals with Merck KGaA, Pfizer and Merck & Co. Collaborations with Eureka Therapeutics and Celularity. The closest of the three to signing a deal with big pharma. World class management and SAB.
2. Chimeric Therapeutics (CHM) - Early stage. High risk. Has the potential to be bigger and better than IMU. World class management and SAB.
3. Radiopharm Theranostics (RAD) - Not invested and not interested. PH has enough of my $$$ invested in his companies...hahaha
- Forums
- ASX - By Stock
- CHM
- Paul Hopper IP opportunists CHM VS RAD
Paul Hopper IP opportunists CHM VS RAD, page-2
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CHM (ASX) to my watchlist
|
|||||
Last
1.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.52M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.8¢ | $3.757K | 198.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 897094 | 1.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 178773 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 897094 | 0.018 |
7 | 1063973 | 0.017 |
18 | 4693527 | 0.016 |
8 | 1935066 | 0.015 |
2 | 2071000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 178773 | 5 |
0.020 | 1636922 | 5 |
0.021 | 975835 | 5 |
0.022 | 300000 | 2 |
0.023 | 335000 | 3 |
Last trade - 10.53am 19/06/2024 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online